Home > News > Pharmaceutical News
Posted on Jul 03, 03:59PM | UNI
Mumbai, Jul 3 : Pharma major, Lupin Ltd. announced today that its subsidiary Lupin Pharmaceuticals Inc. has received approval for its Norgestimate and Ethinyl Estradiol Tablets, 0.18 mg/0.025 mg,0.215 mg/0.025 mg and 0.25 mg/0.025 mg from the United States Food and Drugs Administration (FDA).
Lupin's Norgestimate and Ethinyl Estradiol Tablets are the AB-rated generic equivalent of Ortho Tri-cyclcn Lo Tablel.0.18 mg/0.025 mg 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, of Janssen Pharmaceuticals, Inc, the company informed BSE.
Norgestimate and Ethinyl Estradiol Tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception, it added.